Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 24-Jun-16 3:36 PM View:  | Hove Anders D Director | Anacor Pharmaceuticals, Inc. (ANAC) | 24-Jun-16 | Disposition | 33,886 | $99.25 | $3,363,190.00 | (100%) 33.89K to 0 | |
| 24-Jun-16 2:58 PM View: | Leschly Mark Director | Anacor Pharmaceuticals, Inc. (ANAC) | 24-Jun-16 | Disposition | 794 | $99.25 | $78,804.50 | (100%) 0.79K to 0 | |
| 24-Jun-16 2:59 PM View: | Rieflin William Jl Director | Anacor Pharmaceuticals, Inc. (ANAC) | 24-Jun-16 | Disposition | 89,000 | $99.25 | $8,833,250.00 | (99%) 89.85K to 0.85K | |
| 24-Jun-16 2:49 PM View: | Zane Lee SVP and Chief Medical Officer | Anacor Pharmaceuticals, Inc. (ANAC) | 24-Jun-16 | Disposition | 44,194 | $99.25 | $4,386,250.00 | (100%) 44.19K to 0 | |
| 24-Jun-16 2:59 PM View: | Rieflin William Jl Director | Anacor Pharmaceuticals, Inc. (ANAC) | 24-Jun-16 | Disposition | 853 | $99.25 | $84,660.20 | (100%) 0.85K to 0 | |
| 24-Jun-16 2:43 PM View: | Berns Paul L President and CEO Director | Anacor Pharmaceuticals, Inc. (ANAC) | 24-Jun-16 | Disposition | 231,311 | $99.25 | $22,957,600.00 | (100%) 231.31K to 0 | |
| 24-Jun-16 3:04 PM View: | Shapiro Lucy Director | Anacor Pharmaceuticals, Inc. (ANAC) | 24-Jun-16 | Disposition | 794 | $99.25 | $78,804.50 | (100%) 0.79K to 0 | |
| 24-Jun-16 2:32 PM View: | Ippolito Vincent P EVP & Chief Commercial Officer | Anacor Pharmaceuticals, Inc. (ANAC) | 24-Jun-16 | Disposition | 68,985 | $99.25 | $6,846,760.00 | (100%) 68.98K to 0 | < 1% |
| 24-Jun-16 2:55 PM View: | Wierenga Wendall D Director | Anacor Pharmaceuticals, Inc. (ANAC) | 24-Jun-16 | Disposition | 794 | $99.25 | $78,804.50 | (100%) 0.79K to 0 | |
| 24-Jun-16 2:44 PM View: | Bell Graeme Executive VP and CFO | Anacor Pharmaceuticals, Inc. (ANAC) | 24-Jun-16 | Disposition | 10,488 | $99.25 | $1,040,930.00 | (100%) 10.49K to 0 | |
| 24-Jun-16 2:56 PM View: | Leonard Keith R Director | Anacor Pharmaceuticals, Inc. (ANAC) | 24-Jun-16 | Disposition | 794 | $99.25 | $78,804.50 | (100%) 0.79K to 0 | |
| 24-Jun-16 2:41 PM View: | Sullivan Ryan T EVP and General Counsel | Anacor Pharmaceuticals, Inc. (ANAC) | 24-Jun-16 | Disposition | 30,132 | $99.25 | $2,990,600.00 | (100%) 30.13K to 0 | |
| 03-Jun-16 9:00 PM View: | Bell Graeme Executive VP and CFO | Anacor Pharmaceuticals, Inc. (ANAC) | 01-Jun-16 | Market Sale (Planned) | 751 | $99.28 | $74,559.30 | (7%) 11.01K to 10.26K | (< 1%) |
| 24-May-16 9:04 PM View: | Leonard Keith R Director | Anacor Pharmaceuticals, Inc. (ANAC) | 23-May-16 | Option Exercise | 9,000 | $14.22 | $127,980.00 | 1134% 0.79K to 9.79K | |
| 24-May-16 9:04 PM View: | Leonard Keith R Director | Anacor Pharmaceuticals, Inc. (ANAC) | 23-May-16 | Market Option Sale | 9,000 | $99.70 | $897,300.00 | (92%) 9.79K to 0.79K | < 1% |
| 18-May-16 5:44 PM View: | Hove Anders D Director | Anacor Pharmaceuticals, Inc. (ANAC) | 16-May-16 | Market Sale (Planned) | 353,881 | $99.59 | $35,241,700.00 | (91%) 387.77K to 33.89K | (< 1%) |
| 29-Apr-16 9:00 PM View: | Sullivan Ryan T EVP and General Counsel | Anacor Pharmaceuticals, Inc. (ANAC) | 29-Apr-16 | Market Sale (Planned) | 3,125 | $66.33 | $207,281.00 | (9%) 33.26K to 30.13K | < 1% |
| 15-Apr-16 9:14 PM View: | Hove Anders D Director | Anacor Pharmaceuticals, Inc. (ANAC) | 14-Apr-16 | Conversion | 257,647 | $31.05 | $7,999,940.00 | 198% 130.12K to 387.77K | |
| 11-Apr-16 4:33 PM View: | Hove Anders D Director | Anacor Pharmaceuticals, Inc. (ANAC) | 08-Apr-16 | Market Sale (Planned) | 4,268 | $70.18 | $299,513.00 | (3%) 134.39K to 130.12K | 3% |
| 11-Apr-16 4:33 PM View: | Hove Anders D Director | Anacor Pharmaceuticals, Inc. (ANAC) | 07-Apr-16 | Market Sale (Planned) | 225,033 | $71.12 | $16,004,400.00 | (63%) 359.42K to 134.39K | 4% |
| 04-Apr-16 8:00 PM View: | Rieflin William Jl Director | Anacor Pharmaceuticals, Inc. (ANAC) | 31-Mar-16 | Option Exercise | 89,000 | $8.33 | $741,080.00 | 10434% 0.85K to 89.85K | |
| 22-Mar-16 9:00 PM View: | Berns Paul L President and CEO Director | Anacor Pharmaceuticals, Inc. (ANAC) | 22-Mar-16 | Market Sale (Planned) | 37,500 | $60.31 | $2,261,620.00 | (14%) 267.81K to 230.31K | 1% |
| 04-Mar-16 9:00 PM View: | Ippolito Vincent P EVP & Chief Commercial Officer | Anacor Pharmaceuticals, Inc. (ANAC) | 02-Mar-16 | Market Sale (Planned) | 9,000 | $63.86 | $574,753.00 | (12%) 76.98K to 67.98K | 3% |
| 05-Feb-16 7:01 PM View: | Berns Paul L President and CEO Director | Anacor Pharmaceuticals, Inc. (ANAC) | 03-Feb-16 | Grant | 14,584 | -- | -- | 6% 253.23K to 267.81K | |
| 05-Feb-16 7:04 PM View: | Ippolito Vincent P EVP & Chief Commercial Officer | Anacor Pharmaceuticals, Inc. (ANAC) | 03-Feb-16 | Grant | 5,000 | -- | -- | 7% 71.98K to 76.98K | |
| 05-Feb-16 7:00 PM View: | Bell Graeme Executive VP and CFO | Anacor Pharmaceuticals, Inc. (ANAC) | 03-Feb-16 | Grant | 5,000 | -- | -- | 83% 6.01K to 11.01K | |
| 05-Feb-16 7:03 PM View: | Sullivan Ryan T EVP and General Counsel | Anacor Pharmaceuticals, Inc. (ANAC) | 03-Feb-16 | Grant | 6,250 | -- | -- | 23% 27.01K to 33.26K | |
| 05-Feb-16 7:06 PM View: | Zane Lee SVP and Chief Medical Officer | Anacor Pharmaceuticals, Inc. (ANAC) | 03-Feb-16 | Grant | 4,375 | -- | -- | 11% 39.67K to 44.04K | |
| 25-Jan-16 9:01 PM View: | Zane Lee SVP and Chief Medical Officer | Anacor Pharmaceuticals, Inc. (ANAC) | 22-Jan-16 | Option Exercise | 11,800 | $7.55 | $89,090.00 | 43% 27.28K to 39.08K | |
| 21-Jan-16 9:00 PM View: | Ippolito Vincent P EVP & Chief Commercial Officer | Anacor Pharmaceuticals, Inc. (ANAC) | 19-Jan-16 | Option Exercise | 20,000 | $19.96 | $399,200.00 | 28% 70.98K to 90.98K | |
| 21-Jan-16 9:00 PM View: | Ippolito Vincent P EVP & Chief Commercial Officer | Anacor Pharmaceuticals, Inc. (ANAC) | 19-Jan-16 | Market Option Sale (Planned) | 20,000 | $95.41 | $1,908,200.00 | (22%) 90.98K to 70.98K | 26% |
| 19-Jan-16 9:00 PM View: | Zane Lee SVP and Chief Medical Officer | Anacor Pharmaceuticals, Inc. (ANAC) | 15-Jan-16 | Market Sale (Planned) | 1,466 | $89.57 | $131,310.00 | (5%) 28.75K to 27.28K | 18% |
| 05-Jan-16 9:31 PM View: | Sullivan Ryan T Sr. VP and General Counsel | Anacor Pharmaceuticals, Inc. (ANAC) | 04-Jan-16 | Market Sale (Planned) | 733 | $111.78 | $81,935.50 | (3%) 27.74K to 27.01K | 37% |
| 05-Jan-16 9:33 PM View: | Ippolito Vincent P EVP & Chief Commercial Officer | Anacor Pharmaceuticals, Inc. (ANAC) | 04-Jan-16 | Market Sale (Planned) | 855 | $112.28 | $96,001.80 | (1%) 71.84K to 70.98K | 37% |
| 05-Jan-16 9:30 PM View: | Berns Paul L President and CEO Director | Anacor Pharmaceuticals, Inc. (ANAC) | 04-Jan-16 | Market Sale (Planned) | 2,533 | $112.35 | $284,582.00 | (< 1%) 254.76K to 252.23K | 37% |
| 17-Dec-15 9:01 PM View: | Zane Lee SVP and Chief Medical Officer | Anacor Pharmaceuticals, Inc. (ANAC) | 15-Dec-15 | Market Option Sale (Planned) | 14,000 | $113.17 | $1,584,350.00 | (33%) 42.75K to 28.75K | 37% |
| 17-Dec-15 5:13 PM View: | Hove Anders D Director | Anacor Pharmaceuticals, Inc. (ANAC) | 15-Dec-15 | Market Sale | 900,000 | $111.25 | $100,125,000.00 | (71%) 1.26M to 359.42K | 36% |
| 17-Dec-15 9:01 PM View: | Zane Lee SVP and Chief Medical Officer | Anacor Pharmaceuticals, Inc. (ANAC) | 15-Dec-15 | Option Exercise | 14,000 | $5.59 | $78,260.00 | 49% 28.75K to 42.75K | |
| 15-Dec-15 9:00 PM View: | Berns Paul L President and CEO Director | Anacor Pharmaceuticals, Inc. (ANAC) | 11-Dec-15 | Option Exercise | 20,000 | $10.00 | $200,060.00 | 8% 254.76K to 274.76K | |
| 15-Dec-15 9:00 PM View: | Berns Paul L President and CEO Director | Anacor Pharmaceuticals, Inc. (ANAC) | 11-Dec-15 | Market Option Sale (Planned) | 20,000 | $117.26 | $2,345,250.00 | (7%) 274.76K to 254.76K | 39% |
| 15-Dec-15 5:09 PM View: | Hove Anders D Director | Anacor Pharmaceuticals, Inc. (ANAC) | 11-Dec-15 | Market Sale | 40,000 | $117.36 | $4,694,400.00 | (3%) 1.3M to 1.26M | 40% |
| 11-Dec-15 7:02 PM View: | Sullivan Ryan T Sr. VP and General Counsel | Anacor Pharmaceuticals, Inc. (ANAC) | 10-Dec-15 | Option Exercise | 10,000 | $15.30 | $153,000.00 | 36% 27.74K to 37.74K | |
| 11-Dec-15 7:02 PM View: | Sullivan Ryan T Sr. VP and General Counsel | Anacor Pharmaceuticals, Inc. (ANAC) | 10-Dec-15 | Market Option Sale (Planned) | 10,000 | $110.41 | $1,104,100.00 | (26%) 37.74K to 27.74K | 36% |
| 11-Dec-15 7:00 PM View: | Ippolito Vincent P EVP & Chief Commercial Officer | Anacor Pharmaceuticals, Inc. (ANAC) | 09-Dec-15 | Option Exercise | 20,000 | $19.96 | $399,200.00 | 28% 71.84K to 91.84K | |
| 11-Dec-15 7:00 PM View: | Ippolito Vincent P EVP & Chief Commercial Officer | Anacor Pharmaceuticals, Inc. (ANAC) | 09-Dec-15 | Market Option Sale (Planned) | 20,000 | $107.90 | $2,158,090.00 | (22%) 91.84K to 71.84K | 34% |
| 12-Nov-15 4:59 PM View: | Hove Anders D Director | Anacor Pharmaceuticals, Inc. (ANAC) | 10-Nov-15 | Acquisition (other) | 73,092 | -- | -- | 4% 1.7M to 1.77M | |
| 12-Nov-15 4:59 PM View: | Hove Anders D Director | Anacor Pharmaceuticals, Inc. (ANAC) | 10-Nov-15 | Disposition (other) | 372,982 | -- | -- | (21%) 1.77M to 1.4M | |
| 12-Nov-15 4:59 PM View: | Hove Anders D Director | Anacor Pharmaceuticals, Inc. (ANAC) | 10-Nov-15 | Market Sale | 100,295 | $103.60 | $10,390,600.00 | (7%) 1.4M to 1.3M | 32% |
| 05-Nov-15 5:59 PM View: | Hove Anders D Director | Anacor Pharmaceuticals, Inc. (ANAC) | 03-Nov-15 | Acquisition (other) | 372,982 | -- | -- | 9% 3.95M to 4.32M | |
| 05-Nov-15 5:59 PM View: | Hove Anders D Director | Anacor Pharmaceuticals, Inc. (ANAC) | 03-Nov-15 | Disposition (other) | 1,500,000 | -- | -- | (35%) 4.32M to 2.82M |
